Employment-related difficulties and distressed living condition in patients with hepatitis B virus: A qualitative and

Taeko Oka1, Hiroaki Enoki2, Yukari Tokimoto3

  • 1Human Environment University, 3-6, Hanazonomachi, Matsuyama, Ehime, Japan.

BMC Public Health
|June 14, 2017
PubMed

Insights

Hepatitis B virus (HBV) infection in Japan leads to significant employment challenges and poverty. These factors increase daily life suffering for affected individuals, highlighting a critical public health issue.

Area of Science:

  • Hepatology
  • Public Health
  • Socioeconomics

Background:

  • An estimated 400,000 people in Japan have the hepatitis B virus (HBV), often due to group vaccinations.
  • Individuals with HBV face challenges including disease progression, employment difficulties, and increased medical costs.
  • The link between daily life suffering and poverty due to HBV-related employment changes remains under-examined.

Purpose of the Study:

  • To clarify employment-related hardships faced by Japanese HBV victims.
  • To analyze the relationship between these hardships and daily life suffering, including poverty.

Main Methods:

  • Qualitative study (KJ method, 107 participants) and quantitative study (questionnaire, 10,000+ participants) involving HBV victims from group vaccinations in Japan.
  • Interviews and surveys covered current condition, treatment, medical expenses, and life difficulties (employment, family).
  • Binomial logistic regression analyzed relationships between daily life suffering and disease, employment, and income status.

Main Results:

  • Qualitative analysis identified themes such as intention to work, workplace misunderstanding of HBV, insurance barriers, medical expense burden, life failure, system dissatisfaction, and desire for life balance.
  • Quantitative analysis revealed significant positive correlations between daily life suffering and liver cancer, part-time/casual employment, and income below the national average.

Conclusions:

  • Employment-related hardships and daily life suffering are prevalent among Japanese individuals with HBV.
  • Increased medical expenses, job loss due to HBV, and resulting poverty significantly elevate the risk of daily life distress.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
302
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
688
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
192